Patents
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/1990
11/25/1990WO1990014007A1 Method for protection from azt side effects and toxicity
11/25/1990CA2057900A1 Method for protection from azt side effects and toxicity
11/22/1990EP0398709A2 Genetic diagnosis of torsion dystonia
11/22/1990EP0397821A1 A novel family of high affinity, modified antibodies for cancer treatment
11/22/1990EP0397798A1 Therapeutic use of anti-t cell immunotoxin for autoimmune diseases
11/22/1990EP0397764A1 Method of reducing immunoglobulin e responses
11/22/1990CA2014036A1 Combinations of selective alpha-adrenergic agonists and antagonists useful in lowering intraocular pressure
11/20/1990US4971998 Menstruation, fenfluramine
11/20/1990US4971991 Physiological function enhancing agents activated by ultrasonic waves for the treatment of tumors
11/20/1990US4971795 Enhancement of the cellular immune response using carbohydrate primed DTH effector cells expressing the CD5+/CD8- phenotype
11/20/1990US4971785 Non-alcoholic delivery system for orally ingestible active ingredients
11/20/1990CA1276640C Substituted anilines and processes for the preparation thereof
11/20/1990CA1276556C Organic acid as catalysts for the erosion of polymers
11/18/1990CA2016227A1 Genetic diagnosis of torsion dystonia
11/17/1990CA2016895A1 Use of gestodene for the production of pharmaceutical agents
11/16/1990WO1990014105A1 Accumulation of drugs into liposomes by a proton gradient
11/16/1990CA2056435A1 Accumulation of drugs into liposomes by a proton gradient
11/15/1990WO1990013650A1 A plasmid dna construct including the gene encoding a mammalian beta-nerve growth factor
11/15/1990WO1990013328A1 Dry powder inhalation device
11/15/1990WO1990013300A1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs)
11/15/1990WO1990013289A1 Antineoplastic solution and method for treating neoplasms
11/15/1990CA2354096A1 Dry powder inhalation device
11/14/1990EP0396560A1 Process for increasing the growth rate and/or utilization of fodder or foodstuffs and/or resistance in animals and humans.
11/13/1990US4970235 Medicaments containing of linolenic acid
11/13/1990US4970202 Pharmaceutical compositions containing non-steroidal anti-inflammatory drugs
11/06/1990WO1990013299A1 Fertility enhancement
11/06/1990CA2054197A1 Fertility enhancement
11/06/1990CA1275951C Lysing or blocking unwanted cells
11/06/1990CA1275928C Suppression of withdrawal symptoms in opioid-induced tolerance or dependence
11/06/1990CA1275922C Treatment of cancer
11/01/1990WO1990012594A1 Novel monoclonal antibody to novel antigen associated with human tumors
11/01/1990WO1990012561A1 Cosmetic composition
11/01/1990WO1990009789A3 Pharmaceutically active agents that impede amyloid formation in vivo
11/01/1990CA2053305A1 Cosmetic composition
10/1990
10/31/1990EP0395294A2 Control of protozoal disease
10/31/1990EP0394928A1 Topical antiviral pharmaceutical composition containing a nonionic surfactant
10/31/1990EP0394920A1 Hair enrichment composition and method of use
10/31/1990DE4011956A1 Verfahren und vorrichtung zur darstellung von sterilen einspritzbaren antibiotikapulvern Method and device for presentation of sterile injectable antibiotic powders
10/30/1990US4966893 Method for treatment of senile dementia
10/28/1990WO1990012597A1 Fibroblast growth factor conjugates
10/28/1990WO1990012586A1 Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions
10/27/1990CA2012727A1 Process and an apparatus for the preparation of sterile injectable powders of antibiotics
10/25/1990CA2015312A1 Control of protozoal disease
10/24/1990EP0394050A2 A method of preparing a freeze-dried formulation containing a drug
10/24/1990EP0393575A1 Neoplasia treatment compositions containing antineoplastic agent and side-effect reducing protective agent
10/24/1990EP0393539A2 Oral preparation containing estradiol valerate
10/24/1990EP0393441A1 Mercapto-acylamino acids
10/24/1990CA2015206A1 Topical antiviral pharmaceutical composition containing a nonionic surfactant
10/24/1990CA2014978A1 Hair enrichment composition and method of use
10/23/1990US4965357 2,5,6-substituted N1 -alkylpyrimidines
10/22/1990WO1990012569A1 Therapeutic use of 5-ht3 receptor antagonists
10/22/1990CA2031214A1 Therapeutic use of 5-ht receptor antagonists
10/21/1990WO1990012579A1 The use of non-absorbable synthetic sulfated polysaccharides to decrease cholesterol absorption
10/18/1990WO1990012091A1 Urokinase-type plasminogen activator receptor
10/18/1990WO1990011781A1 The use of liposomes for the delivery of therapeutic agents to wounds, cuts and abrasions
10/18/1990WO1990011769A1 Therapeutic compounds, compositions and uses thereof
10/18/1990WO1990011766A1 Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinaceous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
10/18/1990WO1990011764A1 Active specific immunotherapy of adenocarcinomas producing immunosuppressive mucins
10/18/1990WO1990011761A1 Treatment of aids dementia, myelopathy and blindness
10/18/1990WO1990011758A2 Use of a potassic agonist in the treatment of glaucoma
10/18/1990WO1990011734A1 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
10/17/1990EP0392300A1 Use of at least one cytokin for the manufacture of a medicament for the systemic treatment of preneoplastic lesions
10/17/1990CA2014732A1 Neoplasia treatment compositions containing antineoplastic agent and side-effect reducing protective agent
10/17/1990CA2014304A1 Monoclonal antibody to novel anitgen associated with human tumors
10/16/1990CA1275246C Process for preparing immunogenic complex
10/11/1990WO1990012003A1 Mercapto-acylamino acids
10/11/1990DE3911202A1 Method for improving the tolerability of drugs which can be administered orally, and pharmaceutical compositions which can be administered orally
10/11/1990CA2051652A1 Mercapto-acylamino acids
10/11/1990CA2014130A1 Use of pharmaceutical compositions containing at least one cytokine for the systemic treatment of preneoplastic lesions
10/10/1990EP0391462A1 Synergistic compositions containing ketanserin
10/10/1990EP0391224A2 Drugs and their uses for treating parasitosis
10/10/1990EP0391172A1 Transdermal therapeutic system with an increased rate of flow of medicament and method for its manufacture
10/10/1990CA2014282A1 Therapeutic compounds, compositions and uses thereof
10/09/1990USRE33375 Treatments employing drug-containing matrices for introduction into cellular lesion areas
10/09/1990US4962105 Selected from benazepril, benazeprilat, and libenzapril, by administering in combination specific pyridyl indole derivatives
10/09/1990CA1275042A1 Immunogenic complex, a method for producing the same, and the use thereof as an immune stimulant, vaccines and reagents
10/08/1990CA2051676A1 Urokinase-type plasminogen activator receptor
10/05/1990CA2013801A1 Synergistic compositions containing ketanserin
10/04/1990WO1990011696A1 Reducing post-prandial plasma large neutral amino acid concentrations
10/04/1990WO1990011085A1 Large multivalent immunogen
10/04/1990WO1990006748A3 Use of certain herbicides in cancer treatment and production of protoporphyrin ix
10/04/1990DE4010368A1 Mittel zur bekaempfung von aids-viren und anderen viren Funds to fight AIDS-virus and other viruses
10/04/1990CA2050585A1 Reducing post-prandial plasma large neutral amino acid concentrations
10/04/1990CA2013770A1 Use of liposomes for the delivery of therapeutic agents to wounds, cuts and abrasions
10/03/1990EP0390071A1 Preservative system for ophthalmic formulations
10/03/1990CN1045791A Inhibition of hiv using synergistic combinations of nucleosides derivatives
10/01/1990CA2013443A1 Pharmaceutical compositions and their use in the treatment of parasitoses
09/1990
09/26/1990EP0389177A2 Pharmaceutical formulation
09/26/1990EP0388817A2 Use of mixed micelles and mixed micelle solutions of immunomodulators
09/26/1990EP0388434A1 Differential delivery of therapeutic agents across the blood brain barrier
09/25/1990US4959358 Drug administration
09/23/1990WO1990011074A1 Parathyroid hypertensive factor
09/21/1990CA2012492A1 Pharmaceutical formulation
09/19/1990EP0388306A2 Method for treating pain associated with herpes-zoster and post-herpetic neuralgia by topical application of local anesthetics
09/19/1990EP0387762A2 Medicament with positive inotropic activity, containing a synergistically active mixture consisting of a benzimidazole and a beta-blocker, its preparation and use
09/19/1990EP0387647A2 High-dispersion pharmaceutical composition
09/18/1990WO1990011081A1 Inhibition of hiv using synergistic combinations of nucleoside derivatives
09/18/1990US4957910 Method and composition for the treatment and prevention of viral infections
09/18/1990CA2050473A1 Inhibition of hiv using synergistic combinations of nucleoside derivatives
09/18/1990CA1274140A1 Injecting apparatus for emergency treatment